{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:44:28Z","timestamp":1777502668198,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1136\/ard.2005.043208","type":"journal-article","created":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T17:30:25Z","timestamp":1205861425000},"page":"575-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Guillain\u2013Barr\u00e9 syndrome in a patient receiving anti-tumour necrosis factor \u03b1 for rheumatoid arthritis: a case report and discussion of literature"],"prefix":"10.1016","volume":"67","author":[{"given":"S","family":"Silburn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"McIvor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"McEntegart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2005.043208_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00002018-200427050-00003","article-title":"Safety of tumour necrosis factor-alpha antagonists","volume":"27","author":"Khanna","year":"2004","journal-title":"Drug Safety"},{"key":"10.1136\/ard.2005.043208_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11926-003-0005-9","article-title":"Lessons learned in the use of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis","volume":"5","author":"Mikuls","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/ard.2005.043208_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","article-title":"Guillain-Barre syndrome: epidemiology, pathophysiology and management","volume":"64","author":"Kuwabara","year":"2004","journal-title":"Drugs"},{"key":"10.1136\/ard.2005.043208_bib4","first-page":"87","article-title":"Present treatment of Guillain-Barre syndrome","volume":"188","author":"Raphael","year":"2004","journal-title":"Bull Acad Natl Med"},{"key":"10.1136\/ard.2005.043208_bib5","first-page":"357","article-title":"Guillain-Barre syndrome: etiology and pathogenesis","volume":"54","author":"Avila-Funes","year":"2002","journal-title":"Rev Invest Clin"},{"key":"10.1136\/ard.2005.043208_bib6","first-page":"2862","article-title":"Successful rechallenge with anti-tumor necrosis factor \u03b1 for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al","volume":"44","author":"Cisternas","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.043208_bib7","series-title":"Update of BSR guidelines for prescribing TNF blockers in adults with rheumatoid arthritis","year":"2004"},{"key":"10.1136\/ard.2005.043208_bib8","unstructured":"Information for the Arthritis Advisory Committee. http:\/\/www.fda.gov\/search\/databases (accessed 28 January 2008)."},{"key":"10.1136\/ard.2005.043208_bib9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","article-title":"Guillain\u2013Barr\u00e9 and Miller\u2013Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy","volume":"54","author":"Shin","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724218616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724218616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2005.043208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T15:40:45Z","timestamp":1736091645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724218616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0003496724218616"],"URL":"https:\/\/doi.org\/10.1136\/ard.2005.043208","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain\u2013Barr\u00e9 syndrome in a patient receiving anti-tumour necrosis factor \u03b1 for rheumatoid arthritis: a case report and discussion of literature","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2005.043208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}